BiomX Inc. (PHGE) - Latest Market Data

Track the most recent price, market cap, volume, and performance data for BiomX Inc. (PHGE).

Download PennyGems on Google Play Download PennyGems on the App Store

Equity Overview

Price & Market Data

Price: $0.475

Daily Change: +$0.475 / 100.0%

Daily Range: $0.452 - $0.647

Market Cap: $17,014,582

Daily Volume: 11,445,411

Performance Metrics

1 Week: 52.48%

1 Month: 41.40%

3 Months: 3.29%

6 Months: -18.78%

1 Year: -67.72%

YTD: -18.65%

Company Details

Employees: 57

Sector: Health technology

Industry: Biotechnology

Country:

Details

BiomX Inc., a clinical-stage biopharmaceutical company, develops products using natural and engineered phage technologies designed to target and kill specific harmful bacteria associated with chronic diseases. The company is developing BX211, a phage therapy, which is in phase 2 clinical study for the treatment of diabetic foot osteomyelitis. It also developing BX004, a phage therapy for cystic fibrosis and non-cystic fibrosis bronchiectasis patients with chronic pulmonary infections caused by Pseudomonas aeruginosa that is in Phase 1b/2a clinical trials. The company was founded in 2015 and is headquartered in Ness Ziona, Israel.

Selected stocks

Jinxin Technology Holding Company (NAMI)

NanoVibronix, Inc. (NAOV)

Carisma Therapeutics, Inc. (CARM)